Wednesday, May 4, 2022

mRNA Vaccines Linked to Higher Cardio-Vascular Deaths in Two New Studies


Two new and important studies suggest increased cardiovascular deaths linked to mRNA vaccines. 

The first study is a preprint with The Lancet *as noted below:

Benn, Christine Stabell and Schaltz-Buchholzer, Frederik and Nielsen, Sebastian and Netea, Mihai G. and Netea, Mihai G. and Aaby, Peter, Randomised Clinical Trials of COVID-19 Vaccines: Do Adenovirus-Vector Vaccines Have Beneficial Non-Specific Effects?. Available at SSRN: or

*Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. 

The second study documents increased cardiovascular events among the under-40 population in Israel during their mRNA vaccine rollout. Findings that the vaccines were associated with more cardiovascular risk than the virus are concerning:

Sun, C.L.F., Jaffe, E. & Levi, R. Increased emergency cardiovascular events among under-40 population in Israel during vaccine rollout and third COVID-19 wave. Sci Rep 12, 6978 (2022).

To reiterate: this study indicates that mRNA vaccines are killing younger people at a higher rate than the virus.

This is terrifying, but unexpected news. I myself experienced 4 months of lasting cardiac pain after a single mRNA Moderna vaccination and I am in excess of 50 years old.

The cost-benefit risk analysis does not support mandatory vaccinations and universities need to update their protocols in particular because their student populations are at GREATEST RISK from mRNA vaccination.

More generally, there is no conceivable rationale for forcing people to get vaccines that do not prevent infection and do not prevent vaccinated people from spreading the virus.


There is NO legitimate rationale for the abrogation of bodily sovereignty. 

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.